Treatment Considerations in HR+/HER2- eBC from ASCO 2023


 

Penn Medicine Updates in Oncology 2023: Adjuvant CDK4/6i for Breast Cancer

111 views
July 7, 2023
0 Comments
Login to view comments. Click here to Login
Treatment Considerations in HR+/HER2- eBC from ASCO 2023